Complexation of the non-steroidal anti-inflammatory drug Nabumetone with modified and unmodified cyclodextrins
[EN]The inclusion of the anti-inflammatory drug, Nabumetone, in α-, β-and hydroxypropylβ-cyclodextrin (CDs) is studied using UV-VIS absorption and steady-state fluorescence emission. Binding constants and thermodynamic parameters of complex formation are determined by spectrofluorimetry. The inclusi...
| Autores: | , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 1999 |
| País: | España |
| Institución: | Universidad de Salamanca (USAL) |
| Repositorio: | GREDOS. Repositorio Institucional de la Universidad de Salamanca |
| OAI Identifier: | oai:dnet:gredos______::96ca134a5621589726214570eeec5e38 |
| Acceso en línea: | http://hdl.handle.net/10366/171051 |
| Access Level: | acceso abierto |
| Palabra clave: | Nabumetone Naproxen Cyclodextrin UV-absorption spectroscopy Fluorescence spectroscopy Thermodynamics Proton NMR Cyclodextrins Spectrometry, Fluorescence ciclodextrinas espectrometría de fluorescencia naproxeno |
| Sumario: | [EN]The inclusion of the anti-inflammatory drug, Nabumetone, in α-, β-and hydroxypropylβ-cyclodextrin (CDs) is studied using UV-VIS absorption and steady-state fluorescence emission. Binding constants and thermodynamic parameters of complex formation are determined by spectrofluorimetry. The inclusion phenomena of Nabumetone with the three cyclodextrins is compared with that of the well known similar anti-inflammatory drug Naproxen. In the case of Nabumetone pronounced differences are observed in the complexation process with each cyclodextrin whereas the respective Naproxen complexes are nearly identical. 1H-NMR experiments show that the inclusion process in Nabumetone can occur either through the substituents in the -2 (butanone) or -6 (methoxy) positions in the naphthalene ring. |
|---|